MACROH2A1 and myelodysplastic syndrome: Evaluating the percentage of mH2A1 positive cells, we found a higher expression in MDS specimens compared to controls (25.65 ± 22.38% vs 7.25 ± 8.53% of controls, p < 0.05; Fig. 1A, B).